EP2863909B1 - Combinations Comprising 4-Methyl-[1,2,4]triazolo[4,3-A]quinoxaline Compounds as Pde 2 Inhibitors and Pde 10 Inhibitors for Use in the Treatment of Neurological or Metabolic Disorders